Company: NKLR
Filing Date: 2025-11-10
Form Type: S-1
Source: 0001213900-25-108246
Chunk: 66

Company: Terra Innovatum Global N.V.
Filing Date: 2025-11-10
Form: S-1
Chunk 66
---
 Shares on Nasdaq
and is thereby subject to the Nasdaq corporate governance listing standards. However, the Nasdaq rules will permit a foreign private issuer
to follow the corporate governance practices of its home country if Terra Innovatum decided to follow the requirements applicable to foreign
private issuers. Certain corporate governance practices in the Netherlands, which is Terra Innovatum’s home country, may differ
significantly from the Nasdaq corporate governance listing standards. For instance, Terra Innovatum would not be required to:

| ● | have a majority of the board be independent (although all                          
 of the members of the audit committee must be independent under the Exchange Act); |

| ● | have a compensation committee or a nominations or corporate           
 governance committee consisting entirely of independent directors; or |

| ● | have regularly scheduled executive sessions with only independent 
 directors each year.                                              |

As a result, if Terra Innovatum opted to rely on
the “foreign private issuer” exemptions, Terra Innovatum’s shareholders would be afforded less protection than they
otherwise would enjoy under the Nasdaq corporate governance listing standards applicable to U.S. domestic issuers.

If analysts do not publish research about Terra’s business or if they publish inaccurate or unfavorable research, Terra’s stock price and trading volume could decline.

The trading market for the ordinary shares of Terra
will depend in part on the research and reports that analysts publish about its business. Terra does not have any control over these analysts.
If one or more of the analysts who cover Terra downgrade its ordinary shares or publish inaccurate or unfavorable research about its business,
the price of its ordinary shares would likely decline. If few analysts cover Terra, demand for its ordinary shares could decrease and
its ordinary shares price and trading volume may decline. Similar results may occur if one or more of these analysts stop covering Terra
in the future or fail to publish reports on it regularly.

Terra may be subject to securities litigation, which is expensive and could divert management attention.

The market price of Terra Ordinary Shares may be
volatile and, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities
class action litigation.

Terra may be the target of this type of litigation
in the future. Securities litigation against Terra could result in substantial costs and divert management’s attention from other
business concerns, which could seriously harm its business.

Future resales of Terra Ordinary Shares after the consummation of the Business Combination may cause the market price of Terra’s securities to drop significantly, even if Terra’s business